Author/Group | Title | Registry Name ID | Identifier | Date Posted/Update | Date accessed | URL |
---|---|---|---|---|---|---|
Author AA, Author BB. | Title of trial. | Registry name identifier: | XXX###. | Updated Month Day, Year. | Accessed Month Day, Year. | xxx.xxx.gov |
Group Name. | Title of trial. | Registry name identifier: | XXX###. | Posted Month Day, Year. | Accessed Month Day, Year. | xxx.xxx.xx |
1. Author AA. Title of trial. ClinicalTrials.gov identifier: NCT123456. Updated April 1, 2021. Accessed November 2, 2021. xxx.xxx.gov
2. Evaluation of phage therapy for the treatment of Escherichia coli and Pseudomonas aeruginosa wound infections in burned patients (PHAGOBURN). ClinicalTrials.gov identifier: NCT02116010. Updated July 23, 2015. Accessed October 13, 2016. https://www.clinicaltrials.gov/ct2/show/NCT02116010
3. Rizzardini G. Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19. ClinicalTrials.gov identifier: NCT04336904. Updated April 8, 2020. Accessed June 15, 2020. https://www.clinicaltrials.gov/ct2/show/NCT04336904
4.German Cancer Research Center. Use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms. EudraCT Identifier: 2011-005603-32/DE. Posted May 30, 2012. Accessed November 2, 2019. https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005603-32/DE